← Back to Search

Financial Navigation for Cancer-Related Financial Toxicity

N/A

Recruiting

Led By Stephanie Wheeler, PhD

Research Sponsored by UNC Lineberger Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must be able to read and speak English

Be older than 18 years old

Must not have

Participants without a cancer diagnosis

Patients diagnosed more than 5 years ago without advanced disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4-6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will study the effects of financial navigation on patients' outcomes in rural and non-rural settings.

Who is the study for?

This trial is for adults over 18 with any type of cancer diagnosed within the last 5 years or living with advanced disease, who are experiencing high financial burden from their care. They must be able to read and speak English and score low on a specific financial toxicity survey.

What is being tested?

The study tests a program called Financial Navigation designed to help reduce the cost-related stress and impact of cancer treatment. It will compare patient outcomes in rural versus non-rural settings across North Carolina.

What are the potential side effects?

Since this trial involves financial counseling rather than medical intervention, there are no direct physical side effects. However, participants may experience changes in stress levels related to finances.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can read and speak English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have not been diagnosed with cancer.

Select...

I was diagnosed over 5 years ago and my disease has not advanced.

Select...

I am under 18 years old or caring for someone who is.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4-6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4-6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

COST (Comprehensive Score for Financial Toxicity) measure

Secondary study objectives

Health-Related Quality of Life (HrQoL) Measures

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Financial NavigationExperimental Treatment1 Intervention

includes a financial toxicity screening measure (COST), baseline and post-intervention surveys, and approximately 2-6 visits with a financial navigator to identify financial assistance resources

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Financial Navigation

2024

N/A

~30

0 / 4Eligibility criteria met